Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy CVRx IncCommon Stock stock | $16.91

Learn how to easily invest in CVRx IncCommon Stock stock.

CVRx Inc. Common Stock is a medical devices business based in the US. CVRx IncCommon Stock shares (CVRX) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy shares in CVRx IncCommon Stock

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CVRX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

CVRx IncCommon Stock stock price (NASDAQ: CVRX)

Use our graph to track the performance of CVRX stocks over time.

CVRx IncCommon Stock shares at a glance

Information last updated 2021-10-25.
Latest market close$16.91
52-week range$14.00 - $29.00
50-day moving average $16.41
200-day moving average $18.68
Wall St. target price$26.67
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-91.86

Buy CVRx IncCommon Stock shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Options, ETFs
Get two free stocks valued between $3.00 and $300 with a deposit to any new account.
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy CVRx IncCommon Stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

CVRx IncCommon Stock price performance over time

Historical closes compared with the close of $16.91 from 2021-10-27

1 week (2021-10-21) 8.05%
1 month (2021-09-28) 7.37%
3 months (2021-07-28) -13.19%
6 months (2021-04-24) N/A
1 year (2020-10-24) N/A
2 years (2019-10-24) N/A
3 years (2018-10-24) N/A
5 years (2016-10-24) N/A

CVRx IncCommon Stock financials

Revenue TTM $9.1 million
Gross profit TTM $4.6 million
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Book value N/A
Market capitalisation $317.6 million

TTM: trailing 12 months

Shorting CVRx IncCommon Stock shares

There are currently 1.2 million CVRx IncCommon Stock shares held short by investors – that's known as CVRx IncCommon Stock's "short interest". This figure is 16.2% up from 1.0 million last month.

There are a few different ways that this level of interest in shorting CVRx IncCommon Stock shares can be evaluated.

CVRx IncCommon Stock's "short interest ratio" (SIR)

CVRx IncCommon Stock's "short interest ratio" (SIR) is the quantity of CVRx IncCommon Stock shares currently shorted divided by the average quantity of CVRx IncCommon Stock shares traded daily (recently around 186126.11464968). CVRx IncCommon Stock's SIR currently stands at 6.28. In other words for every 100,000 CVRx IncCommon Stock shares traded daily on the market, roughly 6280 shares are currently held short.

To gain some more context, you can compare CVRx IncCommon Stock's short interest ratio against those of similar companies.

However CVRx IncCommon Stock's short interest can also be evaluated against the total number of CVRx IncCommon Stock shares, or, against the total number of tradable CVRx IncCommon Stock shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CVRx IncCommon Stock's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 CVRx IncCommon Stock shares in existence, roughly 60 shares are currently held short) or 0.1126% of the tradable shares (for every 100,000 tradable CVRx IncCommon Stock shares, roughly 113 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against CVRx IncCommon Stock.

Find out more about how you can short CVRx IncCommon Stock stock.

CVRx IncCommon Stock share dividends

We're not expecting CVRx IncCommon Stock to pay a dividend over the next 12 months.

You may also wish to consider:

CVRx IncCommon Stock overview

CVRx, Inc. develops an implantable technology for the treatment of high blood pressure/hypertension and heart failure patients. It offers BAROSTIM NEO, a neuro-modulation therapy that triggers the body's natural reflex to regulate blood pressure and the underlying causes of the progression of heart failure, which is delivered through a long-lasting implant system, and customized to each patient's individual therapy needs. The company serves patients and healthcare professionals. CVRx, Inc. was incorporated in 2000 and is based in Minneapolis, Minnesota. It has operations in the United States, the United Kingdom, the Netherlands, Italy, Germany, and internationally.

Frequently asked questions

What percentage of CVRx IncCommon Stock is owned by insiders or institutions?
Currently 8.798% of CVRx IncCommon Stock shares are held by insiders and 78.283% by institutions.
When does the fiscal year end for CVRx IncCommon Stock?
CVRx IncCommon Stock's fiscal year ends in December.
Where is CVRx IncCommon Stock based?
CVRx IncCommon Stock's address is: 9201 West Broadway Avenue, Minneapolis, MN, United States, 55445
What is CVRx IncCommon Stock's ISIN number?
CVRx IncCommon Stock's international securities identification number is: US1266381052

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site